###begin article-title 0
###xml 94 99 <span type="species:ncbi:9606">human</span>
A potential role of alternative splicing in the regulation of the transcriptional activity of human GLI2 in gonadal tissues
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
Mammalian Gli proteins are important transcription factors involved in the regulation of Sonic hedgehog signal transduction pathway. Association of Gli2 with mammalian development and human disease led us to study the structure and expression of the human GLI2.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 248 252 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 325 330 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 392 396 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 407 411 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 420 428 404 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 564 568 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 661 665 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 721 725 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
We show that the region encoding GLI2 repressor domain is subject to alternative splicing in the gonadal tissues and different cell lines. Two major alternatively spliced forms of GLI2 mRNA arise from skipping exon 3 (GLI2Delta3) or exons 4 and 5 (GLI2Delta4-5). Both forms contain premature translational stop codons in the GLI2 open reading frame (ORF) starting from exon 2. Translation of GLI2Delta3 and GLI2Delta4-5 in vitro, initiated from downstream AUG codons, produced N-terminally truncated proteins. In Gli-dependent transactivation assay, expression of GLI2Delta3 induced activation of the reporter gene similar to that of the full-length construct (GLI2fl) containing complete ORF. However, expression of the GLI2Delta4-5 resulted in about 10-fold increase in activation, suggesting that deletion of the major part of repressor domain was responsible for the enhanced activation of GLI2 protein.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Our data suggest that in addition to proteolytic processing, alternative splicing may be another important regulatory mechanism for the modulation of repressor and activator properties of GLI2 protein.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
Segment polarity genes induce signaling pathways that direct morphogenesis by giving cells positional information that in turn is translated into appropriate differentiation programs. The Sonic hedgehog (Shh) signaling pathway is required in many tissues for embryonic patterning, cell proliferation and differentiation [1-3]. Inappropriate activation of the pathway drives tumorigenesis in the skin [4-8] and other tissues [9-11].
###end p 9
###begin p 10
###xml 40 51 40 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 893 902 893 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1074 1076 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 151 160 <span type="species:ncbi:7227">fruit fly</span>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
The Cubitus interruptus protein (Ci) in Drosophila and Gli proteins in mammals are the transcriptional effectors of the Shh signaling pathway. Like in fruit fly, multiple Gli transcription factors in vertebrates participate in the transduction of Shh signal and may repress transcription of Shh target genes [12,13]. Similarly to Ci, Gli2 and Gli3 can be proteolytically processed forming an N-terminal repressor that is concentrated in the nucleus [12-15]. Interestingly, deletion of N-terminal fragment of mouse Gli2 containing putative repressor domain altered skin tumor phenotype [5]. Hedgehog (Hh) signaling controls Ci protein activity at the post-translational level. In the absence of the Hh signaling Ci is processed into a truncated repressor form which can inhibit Hh target genes [16]. Loss of Hh function results in all Ci being converted into the repressor form [17]. Different in vitro functions of Gli proteins suggest that Gli2 and Gli3 respond to and are activated by Shh signaling, whereas Gli1 is a transcriptional target of activated Gli2 and Gli3 [12,18].
###end p 10
###begin p 11
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 436 442 <span type="species:ncbi:10090">murine</span>
Several studies reveal how Gli proteins are regulated in the cytoplasm through vertebrate protein Supressor of fused (Sufu), previously identified in flies as having antagonistic role in Hh signaling [19-21]. Sufu can sequester Gli proteins in the cytoplasm, but can also interact with Gli bound to DNA. Thus, Sufu is considered to be a key negative regulator of the Hh signaling pathway in vertebrates [20]. Targeted disruption of the murine suppressor of fused gene (Sufu) led to a phenotype that included neural tube defects and lethality at mid-gestation [22].
###end p 11
###begin p 12
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
It has been proposed that Hh signaling leads to the inhibition of Sufu, deposphorylation of Glis and the production of transcriptionally active forms with enhanced nuclear import [23]. A short motif of four amino acids (aa), SYGH, is required for the interaction of Sufu with Gli. The activity of Gli transcription factors with mutations in this motif is no longer suppressed by co-expression with SUFU [21].
###end p 12
###begin p 13
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli </italic>
###xml 134 142 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 384 388 384 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 547 557 547 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2;Gli3 </italic>
###xml 683 688 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli3 </italic>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 804 809 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1009 1011 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1089 1094 1089 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI3 </italic>
###xml 1105 1107 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 798 803 <span type="species:ncbi:9606">human</span>
###xml 1046 1051 <span type="species:ncbi:10090">mouse</span>
###xml 1056 1061 <span type="species:ncbi:9606">human</span>
Each Gli has distinct activities that are analogous to the regulatory properties of Ci [13]. The first studies on mammalian Gli genes in vivo revealed the combinatorial action of genes. In fact, Gli1 and Gli2, but not Gli1 and Gli3 have extensive overlapping functions [24,25]. Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of Shh pathway [26]. Gli2-/- mice die at birth exhibiting defects in floor plate and adjacent interneuron development, as well as in vertebrae, bones and lungs [1,3,27,28]. Interestingly, Gli2;Gli3 double mutant mice develop more severe defects in skeleton and foregut derivatives than either single mutant, indicating that Gli2 and Gli3 possess both unique and overlapping functions [3,27]. In addition, loss-of-function mutations in the human GLI2 gene are associated with a distinctive phenotype whose primary features include defective anterior pituitary formation and pan-hypopituitarism, with or without overt forebrain cleavage abnormalities [29]. Similarly, several disorders of mouse and human development, are caused by GLI3 mutations [30,31] and references therein.
###end p 13
###begin p 14
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 121 126 <span type="species:ncbi:9606">Human</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 677 682 <span type="species:ncbi:9606">human</span>
Despite of extensive gene targeting studies, there have been no comprehensive studies on the structure of the Gli2 gene. Human GLI2 was originally identified as a Tax-helper protein (THP) that binds to Tax-responsive element in the long terminal repeat of the human T-cell leukemia virus [32]. However, when compared to orthologous Gli2 genes from different species, the human mRNAs lacked a part of the 5' region encoding the evolutionarily conserved N-terminus of Gli2. Recently, Roessler et al. [33] have discovered a 5' sequence encoding 328 aa and showed that this so far undescribed amino-terminal repressor domain was essential for the dominant negative activity of the human GLI2. The transcription repression activity of C-terminally truncated Gli variants has been demonstrated by two independent studies showing that Gli2 and Gli3 proteins contained separate transcription repressor and activator domains [12] which in case of Gli3 were regulated by proteolytic processing [12,14,15]. However, in contrast to Gli3, overexpressed Gli2 was not processed efficiently [13]. Thus, the exact mechanism of repressor generation remains unclear, leaving us with a question whether mechanisms other than proteolytic processing may influence the functional activity of Gli2.
###end p 14
###begin p 15
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 274 279 <span type="species:ncbi:9606">human</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 785 790 <span type="species:ncbi:9606">human</span>
To study the potential role of mRNA splicing in generation of different GLI2 protein variants, we determined the exon-intron organization of human GLI2 and analyzed tissue-specific distribution of GLI2 mRNA and its alternatively spliced forms. Here we show that the revised human GLI2 contains an alternative 5' noncoding exon and its last coding exon encompasses a 1822 bp-long 3' UTR. Comparison with the mouse Gli2 gene/mRNA confirmed the presence of exons 3-6 in the human GLI2 [33]. Two novel alternatively spliced forms of GLI2 generated by skipping exon 3, or exons 4 and 5 were detected in ovary and testis. These forms showed different activator properties in the GLI-dependent transactivation assay. Our results suggest that alternative splicing in the 5' terminal region of human GLI2 mRNA plays an important role in regulation of GLI2 expression and generation of protein isoforms with different activities.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human GLI2 contains four exons encoding amino-terminal repressor domain
###end title 17
###begin p 18
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 751 756 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 122 127 <span type="species:ncbi:10090">Mouse</span>
###xml 244 249 <span type="species:ncbi:10090">mouse</span>
###xml 745 750 <span type="species:ncbi:10090">Mouse</span>
To identify common structural elements of the human and mouse Gli2 genes, we compared their genomic structures and mRNAs. Mouse Gli2 gene contains 14 exons located in about 220 kb region on the chromosome 1E2+3, as revealed by alignment of the mouse Gli2 mRNA [GenBank: ][34] to the corresponding genomic contig [GenBank: ](Fig. 1). Extension of the published mRNA sequence [34] by 180 nucleotides (nt) in the 5' untranslated region (UTR) and 543 nt in the 3' UTR using overlapping EST sequences [GenBank:  and AW546128/BC031171] generated mRNA of 6576 nt. The last exon has 1651 nt of 3' UTR and contains a polyadenylation signal ATTAAA, located 15 nt upstream of the polyA addition site. The location of the cap site of the mRNA is not known. Mouse Gli2 mRNA has a coding region of 1544 aa predicting a protein of 165 kD [34].
###end p 18
###begin p 19
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 821 822 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1069 1074 1069 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1336 1341 1336 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1377 1379 1377 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1671 1676 1671 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 1696 1698 1696 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 262 267 <span type="species:ncbi:9606">human</span>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
###xml 372 377 <span type="species:ncbi:9606">human</span>
###xml 433 438 <span type="species:ncbi:9606">human</span>
###xml 468 473 <span type="species:ncbi:10090">mouse</span>
###xml 596 601 <span type="species:ncbi:9606">human</span>
###xml 695 700 <span type="species:ncbi:9606">human</span>
###xml 1632 1637 <span type="species:ncbi:9606">human</span>
###xml 1665 1670 <span type="species:ncbi:10090">mouse</span>
To characterize the exon-intron organization of human GLI2, we aligned human ESTs [GenBank: , , ,  and ] and human and mouse Gli2 mRNAs [GenBank:  and ] to the human genomic contig [GenBank: ]. These alignments revealed that, similarly to the mouse counterpart, human GLI2 consists of 14 exons spanning 250 kb on the chromosome 2q14 (Fig. 1). Comparison between mouse and human Gli2 structures predicted the presence of exons 3-6 of human GLI2 similar to those of the mouse Gli2. This conclusion confirms earlier finding of Roessler et al. [33], who demonstrated the presence of exons 3-6 in the human GLI2 mRNA, although details of their prediction have not been described. The complete ORF of human GLI2 starts from exon 2 and terminates in exon 14 predicting a protein of 1569 aa with molecular weight of 166 kD (Fig. 4). The predicted protein structure differs from that described by Roessler et al. [33] by a17 aa sequence (GQVSGHGSCGCALPLSQ). This extra sequence is present in the published protein sequence [GenBank: ] that is derived from alternatively spliced GLI2 mRNA [GenBank: ] [33]. The respective mRNA is spliced using alternative acceptor splice site located 51 nt upstream from the boundary of intron 8 and exon 9. It should be noted that alternative splicing involving 51 nt deletion/insertion in the coding region of GLI2 mRNA has been described previously [32]. Since our RT-PCR reaction using primers derived from exons 2 and 14 (see Methods) yielded the major product of 2481 bp lacking the 51 nt in exon 9, we believe that the GLI2 protein used in our studies represents the predominant form (1569 aa) of the human GLI2 protein. In addition, mouse Gli2 mRNA coding region [34] lacks the respective 51 nt sequence.
###end p 19
###begin p 20
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
###xml 139 146 <span type="species:ncbi:9031">chicken</span>
###xml 161 170 <span type="species:ncbi:7955">zebrafish</span>
###xml 339 344 <span type="species:ncbi:10090">mouse</span>
###xml 364 371 <span type="species:ncbi:9031">chicken</span>
###xml 395 404 <span type="species:ncbi:7955">zebrafish</span>
GLI2 protein is conserved throughout vertebrate evolution, showing high degree of sequence identity to its orthologs from mouse (83%)[34], chicken (68%)[35] and zebrafish (56%)[36] (IP unpublished data). Conservation of the N-terminus (residues 61-284), containing putative repressor domain [12], is even more striking - 94% identity with mouse, 87% identity with chicken, and 78% identity with zebrafish (Fig. 2).
###end p 20
###begin title 21
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
GLI2 has two alternative 5' noncoding exons and extension in the 3' UTR
###end title 21
###begin p 22
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 662 669 662 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1132 1139 1132 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1183 1188 1183 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1221 1226 1221 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1357 1362 1357 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1484 1489 1484 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 244 249 <span type="species:ncbi:9606">human</span>
###xml 251 256 <span type="species:ncbi:10090">mouse</span>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
###xml 306 309 <span type="species:ncbi:10116">rat</span>
###xml 314 317 <span type="species:ncbi:9615">dog</span>
###xml 708 713 <span type="species:ncbi:9606">human</span>
###xml 1020 1025 <span type="species:ncbi:9606">human</span>
###xml 1206 1211 <span type="species:ncbi:9606">human</span>
###xml 1351 1356 <span type="species:ncbi:9606">human</span>
Comparison of human and mouse Gli2 transcripts (e.g. [GenBank:  and ] with the human genomic sequence predicted two alternative 5' noncoding exons in the human GLI2 locus, designated exon 1a and 1b (Fig. 1). Exon 1a is highly conserved between human, mouse (corresponds to exon 1 in mouse Gli2 in Fig. 1), rat and dog, showing 75-83% identity at the nucleotide level (data not shown). It is about 60 kb upstream of the exon 2 (the first coding exon). Exon 1b is located about 5 kb upstream of exon 2 and corresponds to the 5' sequence of the original GLI2 mRNA, cloned from HTLV-1-infected Hut102 cells [32]. To determine whether exons 1a and 1b are transcribed in vivo, we amplified the GLI2 5' region from human cell line and tissue cDNAs using forward and reverse primers annealing to exons 1a or 1b and 3, respectively. Amplification products of predicted size and sequence were obtained for exon 1a (315 bp) as well as exon 1b (295 bp) using cDNAs derived from ovary, testis, teratocarcinoma cell line NTera2D1 and human embryonic kidney cell line HEK293 (Fig. 3A). This result shows that both alternative first exons are used in vivo. Although we did not quantify the level of GLI2 mRNA in different human tissues, GLI2 transcripts containing exon 1a seemed to be more abundant than those containing exon 1b. In summary, these results show that human GLI2 locus harbors two alternative 5' noncoding exons, one of which is highly conserved and has not been described before. The GLI2 cDNA sequences encompassing exons 1a and 1b have been deposited in GenBank under accession numbers  and , respectively.
###end p 22
###begin p 23
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 373 378 <span type="species:ncbi:10090">mouse</span>
The published human GLI2 mRNAs [32] lack about two thirds of the 3' UTR (in exon 14) when compared to the mouse Gli2 3' UTR. Comparison with human ESTs [GenBank: ,  and ] and genomic sequence () predicts that the human GLI2 mRNA has a 1822 nt-long 3' UTR containing polyadenylation signal ATTAAA. This signal and its surrounding region are well conserved between human and mouse Gli2 suggesting their requirement for polyadenylation. This fact is also supported by two GLI2 ESTs that terminate with poly(A) sequences 16 nt downstream of the signal [GenBank:  and ].
###end p 23
###begin p 24
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 800 805 800 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 871 872 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 748 753 <span type="species:ncbi:10090">mouse</span>
###xml 794 799 <span type="species:ncbi:9606">human</span>
To confirm the presence of the predicted 3' UTR in the GLI2 transcripts, RT-PCR with 3' UTR-specific primers was carried out. Amplification products of the predicted size (1616 bp) and sequence were obtained for cDNAs derived from gonadal tissues and two human cell lines (Fig. 3B). This result shows that human GLI2 mRNA has an extended 3' UTR as predicted from the bioinformatic analysis. Another potential polyadenylation signal AATAAA, located 1119 nt upstream, has been described earlier [32]. However, this may rather represent a cloning arfefact, since this motif is followed by an A-rich region (AAAAAGGAAAGAAAAAA) known to cause oligo-dT mispriming during cDNA synthesis [37] (Fig. 4). Futhermore, this A-rich sequence is not conserved in mouse Gli2 gene. The revised structure of the human GLI2 mRNA containing complete ORF and its translation is shown in Fig. 4.
###end p 24
###begin title 25
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
Identification of novel alternatively spliced forms of GLI2 mRNA
###end title 25
###begin p 26
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 996 997 996 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 385 390 <span type="species:ncbi:9606">human</span>
###xml 916 921 <span type="species:ncbi:9606">human</span>
We decided to study GLI2 expression in different human tissues because our gene/mRNA structure analysis predicted the existence of mRNA alternatively spliced forms. To determine the expression profile of human GLI2 mRNA, we carried out PCR with primers derived from exons 2 and 7. PCR products of the expected size (918 bp) were observed for a number of commercial cDNAs and different human cell lines. Figure 5A shows that GLI2 mRNA is strongly expressed in the ovary, testis, pancreas, liver, small intestine and thymus. While low level of expression was observed for a number of tissues (e.g., placenta, prostate and colon), almost no expression was detected in heart, brain and peripheral blood leukocytes. Three 0.9 kb products of identical size obtained from prostate, ovary and spleen cDNAs were selected for cloning and sequencing. Sequencing of two randomly selected clones from each cloning confirmed that human GLI2 mRNA contained exons 3-6, as predicted from the gene structure (Fig. 1). The cloned sequence encompassing exons 2-7 is available in GenBank under accession number .
###end p 26
###begin p 27
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 914 919 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1032 1033 1032 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 814 819 <span type="species:ncbi:9606">human</span>
We also detected three minor RT-PCR products corresponding to GLI2 transcript variants approximately 100 and 400 bp shorter than GLI2 mRNA described above. These transcripts were present exclusively in ovary, testis and different cell lines (Fig. 5). Sequencing of 2-3 individual cDNA clones (RT-PCR cloning from ovary, testis and NTera2D1 cells) corresponding to these variants showed that they represented three different types of alternative splicing (Fig. 6). Type I clones had exon 3 spliced to exon 6. Type II clones showed similar skipping of exons 4 and 5, but had a different splice acceptor site between exons 6 and 7. Type III clones had exon 2 spliced to exon 4. Representative sequences of each type of splicing are available in GenBank under accession numbers ,  and . These results show that in the human tissues, GLI2 mRNA may be represented by three different alternatively spliced forms. For all GLI2 mRNA alternatively spliced forms described, the major ORF starting from the exon 2 with the sequence METSA (Fig. 6) was followed by premature termination codon. Thus, translation from the alternatively spliced forms is possible only from downstream initiator codons in frame with the main ORF.
###end p 27
###begin title 28
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
Alternative splicing of GLI2 mRNA is responsible for the synthesis of GLI2 protein isoforms with different activities
###end title 28
###begin p 29
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 203 207 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 378 386 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 393 395 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 407 411 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 424 428 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 542 547 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 681 686 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 737 739 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 788 792 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
We hypothesized that splicing within the first seven exons may be involved in the exclusion or inclusion of the repressor domain of GLI2 protein. To test if alternatively spliced isoforms GLI2Delta3 and GLI2Delta4-5 can produce functional proteins, the corresponding cDNAs were subcloned into pCDNA3 expression vector and tested for the production of proteins using translation in vitro. Fig. 7A shows that GLI2Delta4-5 and GLI2Delta3 generate N-terminally truncated proteins with approximate sizes 155 kDa and 160 kDa, respectively. Because GLI2 ORF starting from the AUG located in exon 2 ended with premature termination codon, translation of the alternatively spliced forms of GLI2 was possible only from downstream AUG codons (Fig. 7B). The low protein yield obtained in the case of GLI2Delta4-5 was apparently due to inefficient translation initiation.
###end p 29
###begin p 30
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 161 165 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 275 279 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 333 337 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 346 347 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 359 363 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
To determine the activation or repression effect of proteins produced from GLI2 mRNA and its alternatively spliced forms, each construct (GLI2fl, GLI2Delta3 and GLI2Delta4-5) was co-transfected with 12XGLIluc reporter plasmid into COS-7 cells. In this transactivation assay, GLI2Delta3 activator effect was comparable to that of the GLI2fl (Fig. 8). However, GLI2Delta4-5 showed about 10-fold increase in the reporter activity, suggesting that the enhanced activation was due to the loss of repressor activity, i.e. excision of repressor domain (or part of it) by alternative splicing.
###end p 30
###begin p 31
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 450 454 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 623 624 615 616 <underline xmlns:xlink="http://www.w3.org/1999/xlink">M</underline>
###xml 638 639 630 631 <underline xmlns:xlink="http://www.w3.org/1999/xlink">M</underline>
###xml 677 678 669 670 <underline xmlns:xlink="http://www.w3.org/1999/xlink">M</underline>
###xml 692 693 684 685 <underline xmlns:xlink="http://www.w3.org/1999/xlink">M</underline>
###xml 725 729 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 751 755 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1039 1043 1023 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1064 1068 1044 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1260 1264 1236 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1333 1337 1305 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1358 1367 1326 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1415 1419 1383 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1491 1495 1455 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1510 1511 1470 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
Transactivation experiments repeated with PTCH promoter, containing two GLI2 binding sites [19], yielded similar results, although in this case about 3-fold enhancement was detected (data not shown). Transcriptional activity of all constructs was significantly suppressed by co-transfection with SUFU construct indicating that SUFU-binding domain, SYGH, encoded by exon 6 was intact in all constructs used. These data show that both GLI2Delta4-5 and GLI2Delta3 generate alternatively spliced forms that can be translated into active proteins. Difference in their activities is most likely caused by the N-terminal sequence MEHYLRSVHSSPTLSMISAARGLSPADVAQEHLKERGLFGLPAPGTTPSDYYHQMTLVAGHPAPYGDLLMQSGGAASAPHLHDYLNPVD, encoded by GLI2Delta3 and missing in GLI2Delta4-5. We suspected that this 89 aa region (or part of it, depending on translation initiation site used) might contain critical sequences required for GLI2 repressor activity. To map these sequences more precisely, we deleted the first 32 aa of the N-terminal sequence encoded of GLI2Delta3 by generating GLI2Delta3BB. Expression of this construct most likely produces an N-terminally truncated protein with translation initiation from the sequence MTLVAG located 54 aa downstream with respect to the GLI2Delta3 translation initiation. This prediction was also supported by GLI2Delta3BB translation in vitro (data not shown). In the transactivation assay, GLI2Delta3BB showed enhanced activation reaching about 70% level of that of GLI2Delta4-5 (Fig. 8), suggesting that 54 aa encoded by exons 4 and 5 were critical for the repressor activity. In summary, our results show that alternative splicing involved in the deletion of the repressor domain encoded by exons 4 and 5 is responsible for the enhanced activation of GLI2 protein.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1066 1070 1066 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1218 1222 1214 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1243 1247 1235 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
###xml 210 215 <span type="species:ncbi:9606">human</span>
###xml 364 369 <span type="species:ncbi:9606">human</span>
###xml 952 957 <span type="species:ncbi:9606">human</span>
In this study we describe the structure of the human GLI2 gene and its expression in different human tissues. A detailed comparison between human and mouse Gli2 structures allowed us to revise the structure of human GLI2 [32,33] by introducing a novel noncoding exon (1a) and extending the 3' UTR. Our data support the earlier finding of Roessler et al. [33] that human GLI2 contains exons 3-6 encoding repressor domain. This domain is highly conserved in evolution and has a major impact on the modulation of GLI2 transcriptional activity. As inferred from the studies on Ci and Gli3, the most likely mechanism that separates repressor and activator domains is proteolytic processing [13,15]. Here we show for the first time that in addition to proteolytic processing, alternative splicing may be another important regulatory mechanism which causes deletion of the major part of repressor domain and thus is responsible for the enhanced activation of human GLI2. In theory, translation from the downstream initiator codon observed in the alternatively spliced form GLI2Delta4-5 is rather inefficient. Nevertheless, the activation effect observed (about 10-fold) is significant, although less protein is produced from GLI2Delta4-5 compared to GLI2fl.
###end p 33
###begin p 34
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
Previous studies of others [12] showed that the removal of the N-terminal region (residues 1-279 encoded by exons 2-6) resulted about 10-fold enhancement of the transcriptional activity of mouse Gli2. Similarly, expression of truncated human GLI2 lacking N-terminal 328 aa, encoded by exons 2-6, demonstrated substantial increase (about 10 to 30-fold) in transcriptional activity of GLI2 [33]. Also, cotransfection experiments showed that the repressor domain encoded by exons 2-6 is involved in the dominant-negative activity of disease-associated GLI2 mutants [33].
###end p 34
###begin p 35
###xml 684 689 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 718 722 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 735 739 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2</italic>
###xml 804 809 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 212 217 <span type="species:ncbi:10090">mouse</span>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 749 754 <span type="species:ncbi:10090">mouse</span>
Taken together, all these results show that the N-terminal region of either mouse or human GLI2 contains a domain with transcriptional repressor activity. While all these results suggest that repressor domain of mouse and human GLI2 is encoded by exons 2-6, our results show the the removal of exons 4-5 alone can affect transcriptional activity of GLI2. Additional mapping of the repressor activity showed that a critical 54 aa-long sequence is encoded by exons 4 and 5. Therefore, our results strongly suggest that alternative splicing may be involved in the regulation of the synthesis of GLI2 proteins with or without repressor activities. Interestingly, we have detected several Gli2 mRNA splice forms, including Gli2Delta4-5 and Gli2Delta3 in mouse embryos, indicating that alternative splicing of Gli2 pre-mRNA may be evolutionarily conserved (Hanna Tulmin, Pille Pata, PK and IP, unpublished data).
###end p 35
###begin p 36
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 677 682 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 851 856 851 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 908 912 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 945 947 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1227 1229 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1299 1303 1295 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 773 778 <span type="species:ncbi:10090">mouse</span>
Previous studies [6,32] have suggested that human GLI2 mRNA may exist in at least four different isoforms, which can be detected in tumor cell lines or tissues. Here we have analyzed alternative splicing in the 5' region of GLI2, encompassing exons 1-7, in normal human tissues. We found that exons 3-5 are involved in the alternative splicing and corresponding alternatively spliced forms (skipping exons 3 and 4-5) were exclusively found in adult ovarian and testicular tissues, raising a question about potential role of GLI2 acting solely as an activator of germ cell development. It should be noted, that knock-in mice expressing full-length Gli2 cDNA from the endogenous Gli2 locus are normal and viable, arguing against the role of alternative transcripts in normal mouse development [25]. Our attempts to detect alternatively spliced forms of GLI2 mRNA, in which exons 2 and 7 were spliced together (GLI2Delta3-6), as described earlier [32], have not been successful. It is likely that different alternatively spliced forms are expressed in tumor cell lines or tissues. However their origin remains unclear. It is also important to note that a highly conserved motif SYGH involved in the interaction of GLI2 with SUFU [21] is encoded by exon 6. Because this exon is lost in the spliced form GLI2Delta3-6, it is possible that its expression gives rise to a GLI2 protein escaping repression and/or sequestration effects of SUFU. We believe that the loss of SUFU binding site of GLI2 protein may have important implications in the regulation of Shh signaling pathway. However, to prove this possibility, additional experiments are required.
###end p 36
###begin p 37
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 314 319 <span type="species:ncbi:9606">human</span>
We have shown that human GLI2 contains two alternative noncoding 5' exons 1a and 1b. This feature typically suggests the usage of alternative promoters and thus adds another layer of complexity to the regulation of human GLI2. It remains to be explored how these promoters can influence the biological function of human GLI2.
###end p 37
###begin title 38
Conclusion
###end title 38
###begin p 39
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
We report here the revised structure of human GLI2 gene. We present evidence that alternative splicing regulates the transcriptional activity of GLI2. Our data suggest that in addition to proteolytic processing, alternative splicing may be another important regulatory mechanism for the modulation of repressor and activator properties of GLI2 protein.
###end p 39
###begin title 40
Methods
###end title 40
###begin title 41
Biocomputational analysis
###end title 41
###begin p 42
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 579 584 <span type="species:ncbi:10090">Mouse</span>
###xml 586 593 <span type="species:ncbi:9031">chicken</span>
###xml 598 607 <span type="species:ncbi:7955">zebrafish</span>
Comparison of the mouse and human GLI2 genomic DNAs and mRNAs was carried out by SPIDEY [38]. Repetitive DNA elements were identified by RepeatMasker (A.F.A. Smit and P. Green, unpublished data). Previously published Gli2 mRNA sequences were extended at their 5' and/or 3' termini using overlapping expressed sequence tags (ESTs) derived from the searches of GenBank database using MEGABLAST [39]. The extended mRNA structures were mapped to the genomic structure by SPIDEY. All translations and mRNA/cDNA sequence comparisons were done with DNAMAN Version 4.0 (Lynnon BioSoft). Mouse, chicken and zebrafish Gli2 protein sequences were derived from databases [GenBank: , , and ].
###end p 42
###begin title 43
Accession numbers
###end title 43
###begin p 44
Sequence data described in this study were deposited into GenBank under accession numbers , , , , , and .
###end p 44
###begin title 45
Reverse transcription, DNA amplification and cloning
###end title 45
###begin p 46
###xml 737 742 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 858 860 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 921 923 903 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 968 973 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1000 1002 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1054 1057 1036 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 392 397 <span type="species:ncbi:9606">human</span>
PCR of the normalized multiple tissue cDNA (MTC) panels I-II (BD Biosciences) and cDNAs prepared from different human cell lines (oligo dT and random priming) was carried out with primers designed into exons 2 (GCCTCCGAGAAGCAAGAAGC) and exon 7 (TGGTGTGTGTCCAAAGGCTGA) using the following temperature profile: 95degreesC 30 s, 55degreesC 30 s and 72degreesC 1 min for 35 cycles. The following human cell lines were used: neuroblastomas SH-SY5Y (ATCC Number: CRL-2266) and SK-N-SH (ATCC Number: HTB-11); mammary gland adenocarcinoma MDA-MB-231 (ATCC Number: HTB-26); glioma G168P44 (a gift from Andres Veske); teratocarcinoma NTera2D1 (ATCC Number: CRL-1973); embryonic kidney HEK293 (ATCC Number: CRL-1573). All PCR products encompassing GLI2 exons 2-7 or their alternatively spliced forms were analyzed by agarose gel electrophoresis, transferred to Hybond N+ membrane (Amersham Biosciences) and hybridized with a 918 nt 32P-labeled riboprobe prepared from the cloned GLI2 cDNA containing exons 2-7 [40]. After gel-elution, PCR products were cloned into SmaI site of the pBluescript SK+ vector (Stratagene) by blunt-end ligation. Recombinant DNAs were isolated and both strands of inserts were sequenced using T3 and T7 primers.
###end p 46
###begin p 47
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 774 777 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 1248 1251 1242 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1260 1263 1254 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 1281 1284 1275 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1289 1292 1283 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 1352 1356 1346 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1379 1384 1373 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 1445 1449 1439 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1460 1464 1450 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1521 1524 1507 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1531 1534 1517 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 1571 1575 1557 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1908 1912 1886 1890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 1940 1944 1914 1918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 2006 2009 1976 1979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 2016 2019 1986 1989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsp</italic>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 203 208 <span type="species:ncbi:9606">human</span>
Cloning of the human GLI2 cDNA containing complete ORF was carried out as follows. First strand cDNA was synthesized with SuperScript III Reverse Transcriptase (Invitrogen) using total RNA isolated from human teratocarcinoma cell line NTera2D1 (ATCC Number: CRL-1973). PCR amplification of cDNA was carried out in two separate experiments. A 2481 bp 5' terminal fragment was generated with primers D3 (TGCTGCTTTACCGACACATC) and R6A (GGAGGAGCGGCGGCTCACG), and a 2290 bp 3' terminal fragment was generated with primers D6 (GGCATCTCCCCCTACTTCTC) and Rev3 (TCTAGGTCATCATGTTCAGGA). PCR conditions were the same as in MTC panel amplification reaction (see above), except that annealing temperature was 55degreesC and extension time 4 min. Both fragments obtained were cloned into SmaI site of the pBluescript SK+ vector. To facilitate blunt-end cloning into expression vector, cloned 5' and 3' terminal fragments together with regions derived from multiple cloning site of the vector were amplified (10 PCR cycles) with a combination of T7 promoter primer and R6A, and T3 promoter primer and D6, respectively. Both gene-specific primers were phosphorylated at 5' termini. The obtained 5' and 3' fragments were joined by blunt-end ligation, digested with HindIII and XbaI and cloned into HindIII-XbaI linearized pCDNA3 expression vector. The final construct, GLI2fl, contained complete GLI2 ORF and its structure was verified by sequencing. Constructs GLI2Delta3 and GLI2Delta4-5 were generated by replacing a region flanked by BamHI and BglII sites (encompassing exons 2-9) in GLI2fl with fragments obtained from alternatively spliced forms (Delta3 and Delta4-5) cloned in pBluescript SK+ vector. Cloning of alternatively spliced forms by RT-PCR was analogous to that described above, except that the following primers derived from exons 2 and 9 were used: GCCTCCGAGAAGCAAGAAGC and ACCTCAGCCTCCTGCTTACA. Construct GLI2Delta3BB was generated from GLI2Delta3 by deleting a 257 bp fragment with restriction enzymes BamHI and BspT1 and blunting the ends with Klenow polymerase. All constructs were verified by DNA sequencing.
###end p 47
###begin p 48
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 317 322 <span type="species:ncbi:9606">human</span>
To analyze expression of alternative first exons 1a and 1b in human tissues and cell lines, PCR was carried out with the forward primers annealing to exon 1a (GGCCACCTGCGTGCTAGAG) or 1b (CCGACACATCAAAGAGCAAGGATTG) and the reverse primer annealing to exon 3 (ACCGTGGACAGAATGAGGCT). We used the first-strand cDNAs from human ovary and testis (BD Biosciences), and cDNAs derived from NTera2D1 and HEK293 cell lines. These cDNAs were synthesized with Superscript III using total RNA. Amplification was conducted at 95degreesC 30 s, 55degreesC 30 s and 72degreesC 1 min for 40 cycles.
###end p 48
###begin p 49
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
To confirm the presence of the predicted 3' UTR in GLI2 transcripts, RT-PCR with primers TTTATGGGCATCCTCTCTGGT and GCATGTCATCTCAATTCATAGCA was used for the amplification of a 1616 bp fragment derived from a region located 27 bp upstream to the polyadenylation signal (ATTAAA). The amplification profile used was identical to that described for exons 1a/1b-3 (above), except that the extension step was 2 min. To exclude the amplification from genomic DNA, RT minus reaction was used as a negative control.
###end p 49
###begin title 50
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro translation and transactivation assay
###end title 50
###begin p 51
###xml 54 58 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 288 293 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 304 310 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2fl</italic>
###xml 312 316 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 324 328 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 341 345 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 636 638 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 824 828 <span type="species:ncbi:9913">calf</span>
In vitro translation assays were carried out using TNT(R) Quick Coupled Transcription/Translation Systems (Promega). COS-7 cell line was used for the luciferase reporter assay. Transfection of cells plated on 24-well plates reaching cell density about 80% was carried out with 0.5 mug of GLI2 construct (GLI2fl, GLI2Delta3, GLI2Delta3BB and GLI2Delta4-5) 0.3 mug of SUFU DNA or empty vector, 0.1 mug 12XGLIluc reporter plasmid and 0.1 mug of pCMV-beta-gal using FuGene (Roche) according to the manufacturer's instructions at DNA to FuGene ratio of 1:3 (w/v). SUFU and reporter plasmid used in this study have been described previously [19]. pCDNA3 plasmid DNA was added to the transfections as needed to achieve the total amount of plasmid DNA per transfection. After 24 h the medium was replaced with low serum media (0.5% calf serum) and cells were incubated for an additional 24 h. Subsequently cells were lysed and luciferase activity was measured with a luciferase kit from Tropix (Bedford) according to the manufacturer's instructions using an Ascent Fluoroscan combined fluori- and luminometer (Thermo Lab-Systems). Luciferase activities were normalized with respect to parallel beta-gal activities, to correct for differences in transfection efficiency. beta-gal assays were performed using Galacto-Light/Galacto-Light Plus Systems (Tropix) according to the manufacturer's instructions. All experiments were repeated at least three times.
###end p 51
###begin title 52
Authors' contributions
###end title 52
###begin p 53
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 86 95 86 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
MS carried out bioinformatic studies, RT-PCR experiments, synthesis of the GLI2 cDNA, in vitro translation and drafted the manuscript. ON carried out transfection experiments and participated in the design of experiments. IP did sequence alignment of Gli2 proteins and RT-PCRs of GLI2 exons 1a/1b-3 and 3'UTR. EV participated in the design of the study and helped to draft the manuscript. PK participated in the design and coordination of the study. All authors read and approved the final manuscript.
###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
We thank Kert Matlik, Richard Tamme and Andres Veske for critical comments. We also thank Andres Veske for a gift of glioma G168P44 cell line and Hanna Tulmin for the help in cDNA synthesis and RT-PCR experiments. This work was supported by the Wellcome Trust International Senior Research Fellowship to PK, by postdoctoral grant from Estonian Ministry of Education and Research to EV and Estonian Science Foundation grants #5171 to MS, #6139 to IP and #5552 and 5933 to PK.
###end p 55
###begin article-title 56
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice
###end article-title 56
###begin article-title 57
Hedgehog signaling in animal development: paradigms and principles
###end article-title 57
###begin article-title 58
Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus
###end article-title 58
###begin article-title 59
Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle
###end article-title 59
###begin article-title 60
Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype
###end article-title 60
###begin article-title 61
###xml 52 57 <span type="species:ncbi:9606">human</span>
Expression of the GLI2 oncogene and its isoforms in human basal cell carcinoma
###end article-title 61
###begin article-title 62
Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2
###end article-title 62
###begin article-title 63
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
###end article-title 63
###begin article-title 64
Brain as a paradigm of organ growth: Hedgehog-Gli signaling in neural stem cells and brain tumors
###end article-title 64
###begin article-title 65
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
###end article-title 65
###begin article-title 66
###xml 28 33 <span type="species:ncbi:9606">Human</span>
Aberrant Methylation of the Human Hedgehog Interacting Protein (HHIP) Gene in Pancreatic Neoplasms
###end article-title 66
###begin article-title 67
Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling
###end article-title 67
###begin article-title 68
Expression of the vertebrate Gli proteins in Drosophila reveals a distribution of activator and repressor activities
###end article-title 68
###begin article-title 69
###xml 18 23 <span type="species:ncbi:9606">human</span>
GLI3 mutations in human disorders mimic Drosophila cubitus interruptus protein functions and localization
###end article-title 69
###begin article-title 70
Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb
###end article-title 70
###begin article-title 71
Proteolysis that is inhibited by hedgehog targets Cubitus interruptus protein to the nucleus and converts it to a repressor
###end article-title 71
###begin article-title 72
An absolute requirement for Cubitus interruptus in Hedgehog signaling
###end article-title 72
###begin article-title 73
Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GLI3
###end article-title 73
###begin article-title 74
Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1
###end article-title 74
###begin article-title 75
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli
###end article-title 75
###begin article-title 76
Characterization of the physical interaction of Gli proteins with SUFU proteins
###end article-title 76
###begin article-title 77
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Cardiac and CNS defects in a mouse with targeted disruption of suppressor of fused
###end article-title 77
###begin article-title 78
The emergent design of the neural tube: prepattern, SHH morphogen and GLI code
###end article-title 78
###begin article-title 79
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation
###end article-title 79
###begin article-title 80
Gli1 can rescue the in vivo function of Gli2
###end article-title 80
###begin article-title 81
Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway
###end article-title 81
###begin article-title 82
Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development
###end article-title 82
###begin article-title 83
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Gli2 is required for induction of floor plate and adjacent cells, but not most ventral neurons in the mouse central nervous system
###end article-title 83
###begin article-title 84
###xml 34 39 <span type="species:ncbi:9606">human</span>
Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features
###end article-title 84
###begin article-title 85
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model of greig cephalopolysyndactyly syndrome: the extra-toesJ mutation contains an intragenic deletion of the Gli3 gene
###end article-title 85
###begin article-title 86
Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome
###end article-title 86
###begin article-title 87
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 120 154 <span type="species:ncbi:11908">human T-cell leukemia virus type 1</span>
Cloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genome
###end article-title 87
###begin article-title 88
###xml 119 124 <span type="species:ncbi:9606">human</span>
A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2
###end article-title 88
###begin article-title 89
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Cloning and sequencing of the mouse Gli2 gene: localization to the Dominant hemimelia critical region
###end article-title 89
###begin article-title 90
Control of somite patterning by Sonic hedgehog and its downstream signal response genes
###end article-title 90
###begin article-title 91
###xml 31 40 <span type="species:ncbi:7955">zebrafish</span>
Comparative synteny cloning of zebrafish you-too: mutations in the Hedgehog target gli2 affect ventral forebrain patterning
###end article-title 91
###begin article-title 92
###xml 22 27 <span type="species:ncbi:9606">human</span>
Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes
###end article-title 92
###begin article-title 93
Spidey: a tool for mRNA-to-genomic alignments
###end article-title 93
###begin article-title 94
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
###end article-title 94
###begin title 95
Figures and Tables
###end title 95
###begin p 96
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gli2 </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Exon-intron organization of the human and mouse <italic>Gli2 </italic>genes</bold>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 356 361 <span type="species:ncbi:9606">human</span>
###xml 459 464 <span type="species:ncbi:10090">mouse</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
Exon-intron organization of the human and mouse Gli2 genes. Gene structures were predicted from the mapping of mouse and human GLI2 mRNAs to the corresponding genomic sequences (GenBank reference accession numbers shown on the right). Exons (numbered) and introns are shown by vertical and horizontal lines, respectively. Alternative 5' noncoding exons in human gene are designated as 1a and 1b. Asterisks indicate exons 3-6, predicted from the comparison of mouse and human Gli2 mRNAs and genomic structures, identified by Roessler et al. [33].
###end p 96
###begin p 97
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Evolutionary conservation of GLI2</bold>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">you-too</italic>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 100 107 <span type="species:ncbi:9031">chicken</span>
###xml 112 121 <span type="species:ncbi:7955">zebrafish</span>
###xml 183 192 <span type="species:ncbi:7955">zebrafish</span>
###xml 316 321 <span type="species:ncbi:9606">human</span>
Evolutionary conservation of GLI2. ClustalW multiple alignment of Gli2 orthologs from human, mouse, chicken and zebrafish species (only N-terminal parts are shown). In the alignment, zebrafish yot protein (encoded by you-too) is shown. Su(fu) binding site SYGH is indicated by asterisks. The initiator methionine of human GLI2 defined by Tanimura et al. [32] is marked by arrowhead.
###end p 97
###begin p 98
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 0 102 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Revised structure of the human <italic>GLI2 </italic>has two alternative 5' noncoding exons and extension in the 3' UTR</bold>
###xml 25 30 <span type="species:ncbi:9606">human</span>
Revised structure of the human GLI2 has two alternative 5' noncoding exons and extension in the 3' UTR. (A) RT-PCR with primers derived from exons 1a-3 and exons 1b-3 are shown (adjoined frames 1a and 1b, respectively). Amplification products, 315 bp for exons 1a-3 and 295 bp for exons 1b-3 are shown. The origin of a 400 bp PCR product in 1b-3 reaction of NTera2D1 is unknown. (B) RT-PCR with primers annealing to the 3' UTR. A1616 bp amplification product is shown. Complementary DNAs used were derived from tissues and cell lines indicated on top. Control, no cDNA.
###end p 98
###begin p 99
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Structure of the human <italic>GLI2 </italic>mRNA and its translation</bold>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 54 59 <span type="species:ncbi:9606">Human</span>
Structure of the human GLI2 mRNA and its translation. Human GLI2 mRNA containing conserved 5' noncoding sequence of 69 nt (exon 1a) and complete 3' UTR (1822 nt) are shown. Poly(A) signal is underlined.
###end p 99
###begin p 100
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tissue-specificity of <italic>GLI2 </italic>mRNA and its alternatively spliced forms</bold>
###xml 147 148 147 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 189 190 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 510 514 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
###xml 664 668 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2</italic>
Tissue-specificity of GLI2 mRNA and its alternatively spliced forms. Southern blot analysis of the PCR products amplified from cDNAs derived from (A) normalized multiple tissue panels and (B) different cell lines (indicated on top of the panel) using GLI2-specific primers derived from exons 2 and 7. The products were hybridized with a 918 nt-riboprobe encompassing GLI2 exons 2-7. Bars on the right indicate sizes of PCR products corresponding to GLI2 mRNA and its alternatively spliced forms GLI2Delta3 and GLI2Delta4-5 (0.9, 0.8 and 0.5 kb, respectively). A shorter and longer exposure were used to determine the presence of minor transcripts corresponding to GLI2Delta3 (0.8 kb) in ovary and testis (panel A). Note the complex pattern of alternatively spliced products observed for cell lines (panel B) that is most likely due to promiscuous splicing (not analyzed in detail). Control, no cDNA.
###end p 100
###begin p 101
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alternative splicing in the 5' end of <italic>GLI2 </italic>mRNA</bold>
Alternative splicing in the 5' end of GLI2 mRNA. Exons corresponding to cloned and/or sequenced splice variants are marked by bold lines. Exon and intron splice junction sequences are designated by upper and lower case letters, respectively. Alternatively spliced forms I-III arising via exon skipping and different exon 6-7 junction usage (described in this study) are compared with the previously published sequence (Type IV) [32]. For each alternatively spliced form, GenBank accession number is shown on the right. Translation of these sequences initiated from ATG codon located in exon 2 (METSA) terminates with premature termination codons (PTC). Location of initiator codon described previously [32] is shown in exon 7 (M). Location of the SUFU binding site (SYGH) in exon 6 is shown.
###end p 101
###begin p 102
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In vitro </italic>translation of the <italic>GLI2 </italic>mRNA and its alternatively spliced forms</bold>
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 100 102 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 277 278 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 149 155 <span type="species:ncbi:9986">rabbit</span>
In vitro translation of the GLI2 mRNA and its alternatively spliced forms. (A) SDS-gel analysis of [35S]-methionine labeled products translated with rabbit reticulocyte lysate. Constructs used are indicated on the top. Molecular weight marker positions are shown on the left. (B) Schematic representation of the translation products of the splice forms (shown on the right, with predicted molecular weight in parenthesis). mRNAs are shown by bold lines and their translation products are drawn by solid boxes. Open box represents translation in a different reading frame. The predicted N-terminal sequences (5 aa) are shown.
###end p 102
###begin p 103
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of the <italic>GLI2 </italic>and its alternatively spliced forms produces protein isoforms with different activities</bold>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLI2 </italic>
Expression of the GLI2 and its alternatively spliced forms produces protein isoforms with different activities. Transactivation assay with luciferase reporter plasmid (12XGLIluc), various GLI2 and SUFU constructs was carried out as described in Methods section using COS-7 cell line.
###end p 103

